Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Lantern Pharma Inc.
NRG Oncology
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Morphotek
Henan Cancer Hospital
SWOG Cancer Research Network
National Cancer Institute (NCI)
Northwestern University
Swiss Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Shanghai Pulmonary Hospital, Shanghai, China
Roswell Park Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
SWOG Cancer Research Network
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins